<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Liver+Neoplasms%2Fchemically+induced%2F%2Aimmunology%2F%2Aprevention+%26+control&amp;sort_field=added&amp;sort_dir=a&amp;output=omeka-xml" accessDate="2026-04-15T18:57:37-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="3245" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="40164">
              <text>&lt;a href="http://doi.org/10.1007/s11095-010-0144-4" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.1007/s11095-010-0144-4&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="40166">
              <text>1080–1091</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="40167">
              <text>6</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="40168">
              <text>27</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="40156">
                <text>Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="40157">
                <text>Pharmaceutical research</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="40158">
                <text>2010</text>
              </elementText>
              <elementText elementTextId="40159">
                <text>2010-06</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="40160">
                <text>Animals; Anticarcinogenic Agents/*therapeutic use; Chemoprevention; Cyclooxygenase 2/immunology; Diethylnitrosamine; Female; HSP70 Heat-Shock Proteins/immunology; Humans; Inflammation/prevention &amp; control; Liver Neoplasms/chemically induced/*immunology/*prevention &amp; control; Liver/drug effects/pathology; NF-kappa B/immunology; Rats; Resveratrol; Sprague-Dawley; Stilbenes/*therapeutic use</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="40161">
                <text>Bishayee Anupam; Waghray Abhijeet; Barnes Kendra F; Mbimba Thomas; Bhatia Deepak; Chatterjee Malay; Darvesh Altaf S</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="40162">
                <text>PURPOSE: Resveratrol, present in grapes and red wine, has been found to prevent diethylnitrosamine (DENA)-initiated rat liver tumorigenesis, though the chemopreventive mechanisms are not completely elucidated. The current study was designed to explore whether the antiinflammatory properties of resveratrol play a role in its antihepatocarcinogenic action. METHODS: Liver samples were harvested from a 20-week chemopreventive study in which resveratrol (50, 100 and 300 mg/kg) was shown to inhibit DENA-induced hepatocyte nodules in Sprague-Dawley rats in a dose-responsive manner. Hepatic preneoplastic and inflammatory markers, namely heat shock protein (HSP70), cyclooxygenase-2 (COX-2) and nuclear factor-kappaB (NF-kappaB), were studied using immunohistochemical as well as Western blot techniques. RESULTS: Resveratrol dose-dependently suppressed DENA-induced increased expressions of hepatic HSP70 and COX-2. Resveratrol also attenuated the</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="40163">
                <text>&lt;a href="http://doi.org/10.1007/s11095-010-0144-4" target="_blank" rel="noreferrer noopener"&gt;10.1007/s11095-010-0144-4&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="40165">
                <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="61">
        <name>2010</name>
      </tag>
      <tag tagId="123">
        <name>Animals</name>
      </tag>
      <tag tagId="22575">
        <name>Anticarcinogenic Agents/*therapeutic use</name>
      </tag>
      <tag tagId="3837">
        <name>Barnes Kendra F</name>
      </tag>
      <tag tagId="2207">
        <name>Bhatia Deepak</name>
      </tag>
      <tag tagId="2208">
        <name>Bishayee Anupam</name>
      </tag>
      <tag tagId="3839">
        <name>Chatterjee Malay</name>
      </tag>
      <tag tagId="3627">
        <name>Chemoprevention</name>
      </tag>
      <tag tagId="3831">
        <name>Cyclooxygenase 2/immunology</name>
      </tag>
      <tag tagId="3840">
        <name>Darvesh Altaf S</name>
      </tag>
      <tag tagId="32950">
        <name>Department of Pharmaceutical Sciences</name>
      </tag>
      <tag tagId="1453">
        <name>Diethylnitrosamine</name>
      </tag>
      <tag tagId="38">
        <name>Female</name>
      </tag>
      <tag tagId="3832">
        <name>HSP70 Heat-Shock Proteins/immunology</name>
      </tag>
      <tag tagId="8">
        <name>Humans</name>
      </tag>
      <tag tagId="3833">
        <name>Inflammation/prevention &amp; control</name>
      </tag>
      <tag tagId="22576">
        <name>Liver Neoplasms/chemically induced/*immunology/*prevention &amp; control</name>
      </tag>
      <tag tagId="2057">
        <name>Liver/drug effects/pathology</name>
      </tag>
      <tag tagId="3838">
        <name>Mbimba Thomas</name>
      </tag>
      <tag tagId="32954">
        <name>NEOMED College of Pharmacy</name>
      </tag>
      <tag tagId="3835">
        <name>NF-kappa B/immunology</name>
      </tag>
      <tag tagId="3830">
        <name>Pharmaceutical research</name>
      </tag>
      <tag tagId="469">
        <name>Rats</name>
      </tag>
      <tag tagId="3706">
        <name>Resveratrol</name>
      </tag>
      <tag tagId="473">
        <name>Sprague-Dawley</name>
      </tag>
      <tag tagId="22505">
        <name>Stilbenes/*therapeutic use</name>
      </tag>
      <tag tagId="3836">
        <name>Waghray Abhijeet</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
